EMS SCV Meetings: SEP 2006 – JUN 2007
Oct 25, 2006:
Management Forum: NanoTech Applications – Dr. Craig Horne
After-dinner Talk: NanoTech in the Bay Area – Dhaval J. Brahmbhatt
Sep 27, 2006:
Management Forum: Retention Factors for Engaging Your Top Engineers (see the slides) – Dr. B. Lynn Ware
After-dinner Talk: Ethical Issues Associated with Commercializing Medical Devices – Dr. Margaret Eaton
Note: no meetings listed on old website for November, 2006 through June, 2007
Jun 27, 2007:
Management Forum: topic to be determined – speaker to be determined
After-dinner Talk: topic to be determined – speaker to be determined
May 30, 2007:
Management Forum: topic to be determined – speaker to be determined
After-dinner Talk: topic to be determined – speaker to be determined
Apr 25, 2007:
Management Forum: topic to be determined – speaker to be determined
After-dinner Talk: topic to be determined – speaker to be determined
Mar 28, 2007:
Management Forum: topic to be determined – speaker to be determined
After-dinner Talk: topic to be determined – speaker to be determined
Feb 28, 2007:
Management Forum: topic to be determined – speaker to be determined
After-dinner Talk: topic to be determined – speaker to be determined
Jan 31, 2007:
Management Forum: topic to be determined – speaker to be determined
After-dinner Talk: topic to be determined – speaker to be determined
Nov 29, 2006:
Management Forum: topic to be determined – speaker to be determined
After-dinner Talk: topic to be determined – speaker to be determined
@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
MEETING SUMMARIES & BIOS
_________________________________________________________________________________________
Oct 25, 2006
Management Forum: NanoTech Applications
Presented by Dr. Craig Horne, Nanogram
Dr. Horne is founder of nanotech startup, Kainos Energy, a subsidiary of Nanogram Corp.
************************************************
After-dinner Talk: NanoTech in the Bay Area
Presented by Dhaval J. Brahmbhatt, PhyChip Corp
Dr. Brahmbhatt is President and CEO of PHYchip Corporation and Chairman of the IEEE SF Bay Area Nanotechnology Council.
_________________________________________________________________________________________
Sep 4, 2008
Management Forum: Retention Factors for Engaging Your Top Engineers (link to slides below)
Presented by Dr. B. Lynn Ware, President & CEO, Integral Talent Systems, Inc.
What key management practices can you use to engage and retain scarce engineering talent that may be motivated to go home and work abroad? What can you do to keep your valued engineers from “jumping ship” now that the economy has improved?
Dr. B. Lynn Ware will present data from a recent study describing how top engineers want to be managed. The data represents 1400 employees and was collected from over 20 Silicon Valley companies over the past four years.
In addition, Dr. Ware will present a validated approach to managing technical talent that has successfully reduced turnover by 23% with both EE’s and IT engineers. You can self assess your management practices against this proven model with a quick inventory that will be distributed for your confidential use at the meeting.
The greater success a manager has in holding on to valued engineers, the higher the productivity in the group and organization, ultimately leading to both short and long term market success in your niche. Come to this meeting and do your part by learning and practicing the management techniques that are in your control to keep the best talent on your team.
Dr. B. Lynn Ware is an Industrial/Organizational Psychologist and the founder and President of Integral Talent Systems, Inc., (ITS) an internationally known Talent Management consulting firm based in Palo Alto, CA. ITS is a pioneer in the employee engagement & retention field. ITS was one of the very first consulting firms dedicated to resolving employee retention issues and began original research in this area in 1995.
ITS now engages with corporate clients to provide guidance on how to create “employer of choice” environments. ITS provides this guidance by continually conducting independent research on talent management issues, developing innovative educational programs and tools, and staying abreast of current corporate and work place trends. These workplace trends and best practices are reported through monthly audio conferences sponsored by ITS.
Dr. Ware has personally practiced for over 20 years as a human resources consultant. She has personally worked with 120 of the Fortune 500 corporations in many industries. She is frequently quoted on trends in talent management strategies in numerous publications such as the Associated Press, Computer World magazine, IQPC, Network World and the San Francisco Chronicle, and has been featured several times on CNN as a national talent management expert.
************************************************
After-dinner Talk: Ethical Issues Associated with Commercializing Medical Devices
Presented by Dr. Margaret Eaton, faculty member, Stanford University
Our after dinner talk will cover some common ethical challenges related to the commercial development of medical devices. Included in the managerial challenges are decisions related to academic conflicts of interest, maturity of device at the time of first human use, pitfalls in clinical research (including placebo surgery), regulatory pathways, training and certification assurances, and fair balancing in marketing campaigns. Dr. Maggie Eaton will draw from her extensive academic work on the ethical and social issues that impact the biotechnology, pharmaceutical, and related industries.
Dr. Eaton teaches at the Stanford University Graduate School of Business. For six years prior to that, she was a Senior Research Scholar in the Center for Biomedical Ethics at the Stanford University School of Medicine. Previously, she held the positions of Assistant Professor at the University of Minnesota School of Pharmacy and Clinical Research Manager at Key Pharmaceuticals, Inc.
Dr. Eaton served as law clerk for Genentech, Inc., where she worked on biotechnology intellectual property and regulatory law projects. She then practiced law as a litigator specializing in pharmaceutical product liability and then served for ten years in the Stanford University Legal Department where she practiced as a medical and hospital attorney.
Dr. Eaton’s current teaching includes courses in biotechnology and pharmaceutical business ethics, medical law, and biomedical ethics. In addition, she is Adjunct Professor, Keck Graduate Institute, Claremont Colleges. Dr. Eaton’s primary academic work focuses on the ethical and social issues that impact the biotechnology, pharmaceutical, and related industries.
She has undergraduate and graduate degrees in pharmacy, clinical pharmacy, and law. Dr. Eaton obtained her law degree (cum laude) from Hastings College of the Law at the University of San Francisco. Among her publications are two books on this subject of issues that impact biotechnology, Ethics and the Business of Bioscience, BioIndustry Ethics (co-authored with others), and a third book in press about the ethical issues associated with the deployment of new medical technologies (written with Donald Kennedy). http://scbe.stanford.edu/people/resumes/eaton.html
_________________________________________________________________________________________